Evidence map›Paper›PMID 19632257›Full record

ArticleToxicology and applied pharmacology2009

Mass spectrometry identifies multiple organophosphorylated sites on tubulin.

Hasmik Grigoryan, Lawrence M Schopfer, Eric S Peeples, Ellen G Duysen, Marine Grigoryan, Charles M Thompson, Oksana Lockridge

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hasmik GrigoryanUniversity of Nebraska Medical Center, Eppley Institute for Cancer Research, 986805 Nebraska Medical Center, Omaha, NE 68198-6805, USA. hgrigoryan@berkeley.edu
Lawrence M Schopfer
Eric S Peeples
Ellen G Duysen
Marine Grigoryan
Charles M Thompson
Oksana Lockridge
University of Nebraska Medical Center · USNebraska Medical Center · USUniversity of Montana · US

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Apar Kishor Ganti · 1985 to 2026
$55.0M
Biomarkers of Organophosphate-Adducted ProteinsU01ES016102 · NIEHS · UNIVERSITY OF MONTANA · PI THOMPSON, CHARLES MARK · 2007 to 2010
$2.2M
Mass Spectrometry in Clinical Diagnosis of Nerve Agent ExposureU01NS058056 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LOCKRIDGE, OKSANA · 2006 to 2008
$1.4M
NCI NIH HHS P30 CA036727NCI NIH HHS P30CA36727NIEHS NIH HHS U01 ES016102NINDS NIH HHS U01 NS058056
6 · The paper itself

Abstract

Acute toxicity of organophosphorus poisons (OP) is explained by inhibition of acetylcholinesterase in nerve synapses. Low-dose effects are hypothesized to result from modification of other proteins, whose identity is not yet established. The goal of the present work was to obtain information that would make it possible to identify tubulin as a target of OP exposure. Tubulin was selected for study because live mice injected with a nontoxic dose of a biotinylated organophosphorus agent appeared to have OP-labeled tubulin in brain as determined by binding to avidin beads and mass spectrometry. The experiments with live mice were not conclusive because binding to avidin beads could be nonspecific. To be convincing, it is necessary to find and characterize the OP-labeled tubulin peptide. The search for OP-labeled tubulin peptides was begun by identifying residues capable of making a covalent bond with OP. Pure bovine tubulin (0.012 mM) was treated with 0.01-0.5 mM chlorpyrifos oxon for 24 h at 37 degrees C in pH 8.3 buffer. The identity of labeled amino acids and percent labeling was determined by mass spectrometry. Chlorpyrifos oxon bound covalently to tyrosines 83, 103, 108, 161, 224, 262, 272, 357, and 399 in bovine alpha tubulin, and to tyrosines 50, 51, 59, 106, 159, 281, 310, and 340 in bovine beta tubulin. The most reactive were tyrosine 83 in alpha and tyrosine 281 in beta tubulin. In the presence of 1 mM GTP, percent labeling increased 2-fold. Based on the crystal structure of the tubulin heterodimer (PDB 1jff) tyrosines 83 and 281 are well exposed to solvent. In conclusion seventeen tyrosines in tubulin have the potential to covalently bind chlorpyrifos oxon. These results will be useful when searching for OP-labeled tubulin in live animals.

Indexed as

Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTandem Mass SpectrometryAnimalsBinding SitesBiotinylationBrainCattleChlorpyrifosChromatography, High Pressure LiquidDose-Response Relationship, DrugHydrogen-Ion ConcentrationKineticsMiceModels, MolecularOrganophosphatesProtein ConformationChlorpyrifosO,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphateOrganophosphatesTubulinTyrosine

Identifiers

PMID19632257
PMCPMC2753752
OpenAlexW2059742200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.